Stiefel Commences Tender Offer to Acquire Barrier Therapeutics

Stiefel Laboratories, Inc. … announced that Bengal Acquisition Inc., a wholly-owned subsidiary of Stiefel Laboratories, has commenced a cash tender offer to purchase all outstanding shares of common stock, par value $0.0001 per share, of Barrier Therapeutics, Inc. …
Fox Business